Addition of plasma exchange to red cell exchange improves outcomes of fat embolism syndrome in sickle cell disease

By sjmartinez • March 8, 2023

Tsitsikas DA, Rowe S, Bosch A, Hui C, Sadasivam N, Palaskas NJ, Pancham S, Rizvi S, Taylor J, Greaves P, Glenthøj A, Hoffmann M, Drasar E, Eleftheriou P. Addition of plasma exchange to red cell exchange improves outcomes of fat embolism syndrome in sickle cell disease. Br J Haematol. 2023 Mar;200(6):e50-e52. doi: 10.1111/bjh.18638. Epub 2023 Jan 3. PMID: 36594271.

Tags: Hematology/Oncology, Publications

Phase 2 trial of PSMA PET CT versus planar bone scan and CT in prostate cancer patients progressing while on androgen deprivation therapy

Nikitas J, Gafita A, Benz MR, Djaïleb L, Farolfi A, Hotta M, Sonni I, Alano R, Rettig M, Shen J, Armstrong W, Grogan T, Liu[...]

First-in-human clinical outcomes with NG-350A, an anti-CD40 expressing tumor-selective vector designed to remodel immunosuppressive tumor microenvironments

Naing A, Khalil D, Rosen O, Camidge DR, Lillie T, Ji RR, Stacey A, Thomas M, Rosen L. First-in-human clinical outcomes with NG-350A, an anti-CD40[...]

Risk of severe immune-related adverse events in cancer patients with pre-existing autoimmunity receiving immune checkpoint inhibitor therapy

Isaacs DJ, Kathuria-Prakash N, Hilder R, Lechner MG, Drakaki A. Risk of severe immune-related adverse events in cancer patients with pre-existing autoimmunity receiving immune checkpoint[...]